BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mailhos C, Modlich U, Lewis J, Harris A, Bicknell R, Ish-Horowicz D. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation. 2001;69:135-144. [PMID: 11798067 DOI: 10.1046/j.1432-0436.2001.690207.x] [Cited by in Crossref: 203] [Cited by in F6Publishing: 187] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 LaFoya B, Munroe JA, Mia MM, Detweiler MA, Crow JJ, Wood T, Roth S, Sharma B, Albig AR. Notch: A multi-functional integrating system of microenvironmental signals. Dev Biol 2016;418:227-41. [PMID: 27565024 DOI: 10.1016/j.ydbio.2016.08.023] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 8.3] [Reference Citation Analysis]
2 Caporarello N, Lupo G, Olivieri M, Cristaldi M, Cambria MT, Salmeri M, Anfuso CD. Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions (Review). Mol Med Rep 2017;16:4393-402. [PMID: 28791360 DOI: 10.3892/mmr.2017.7179] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
3 Harrington LS, Sainson RC, Williams CK, Taylor JM, Shi W, Li J, Harris AL. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research 2008;75:144-54. [DOI: 10.1016/j.mvr.2007.06.006] [Cited by in Crossref: 142] [Cited by in F6Publishing: 140] [Article Influence: 10.1] [Reference Citation Analysis]
4 Tozer GM, Bicknell R. Therapeutic targeting of the tumor vasculature. Seminars in Radiation Oncology 2004;14:222-32. [DOI: 10.1016/j.semradonc.2004.04.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
5 Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett 2012;320:130-7. [PMID: 22425960 DOI: 10.1016/j.canlet.2012.03.008] [Cited by in Crossref: 225] [Cited by in F6Publishing: 221] [Article Influence: 22.5] [Reference Citation Analysis]
6 An SY, Heo JS. Low oxygen tension modulates the osteogenic differentiation of mouse embryonic stem cells. Tissue Cell 2018;52:9-16. [PMID: 29857833 DOI: 10.1016/j.tice.2018.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Joosten SC, Hamming L, Soetekouw PM, Aarts MJ, Veeck J, van Engeland M, Tjan-Heijnen VC. Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives. Biochim Biophys Acta 2015;1855:1-16. [PMID: 25446042 DOI: 10.1016/j.bbcan.2014.11.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
8 Mochizuki K, Xie F, He S, Tong Q, Liu Y, Mochizuki I, Guo Y, Kato K, Yagita H, Mineishi S, Zhang Y. Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice. J Immunol 2013;190:3772-82. [PMID: 23440416 DOI: 10.4049/jimmunol.1202820] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
9 Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 2004;18:2474-8. [PMID: 15466159 DOI: 10.1101/gad.1239004] [Cited by in Crossref: 416] [Cited by in F6Publishing: 377] [Article Influence: 23.1] [Reference Citation Analysis]
10 Harris PJ, Speranza G, Dansky Ullmann C. Targeting embryonic signaling pathways in cancer therapy. Expert Opinion on Therapeutic Targets 2012;16:131-45. [DOI: 10.1517/14728222.2011.645808] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
11 Borggrefe T, Lauth M, Zwijsen A, Huylebroeck D, Oswald F, Giaimo BD. The Notch intracellular domain integrates signals from Wnt, Hedgehog, TGFβ/BMP and hypoxia pathways. Biochim Biophys Acta 2016;1863:303-13. [PMID: 26592459 DOI: 10.1016/j.bbamcr.2015.11.020] [Cited by in Crossref: 103] [Cited by in F6Publishing: 108] [Article Influence: 14.7] [Reference Citation Analysis]
12 Stella MC, Trusolino L, Pennacchietti S, Comoglio PM. Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol 2005;25:3982-96. [PMID: 15870272 DOI: 10.1128/MCB.25.10.3982-3996.2005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
13 Schröder N, Gossler A. Expression of Notch pathway components in fetal and adult mouse small intestine. Gene Expr Patterns 2002;2:247-50. [PMID: 12617809 DOI: 10.1016/s1567-133x(02)00060-1] [Cited by in Crossref: 119] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
14 Basu S, Barbur I, Calderon A, Banerjee S, Proweller A. Notch signaling regulates arterial vasoreactivity through opposing functions of Jagged1 and Dll4 in the vessel wall. Am J Physiol Heart Circ Physiol 2018;315:H1835-50. [PMID: 30168730 DOI: 10.1152/ajpheart.00293.2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Qiao L, Wong BC. Role of Notch signaling in colorectal cancer. Carcinogenesis. 2009;30:1979-1986. [PMID: 19793799 DOI: 10.1093/carcin/bgp236] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
16 Varghese E, Liskova A, Kubatka P, Mathews Samuel S, Büsselberg D. Anti-Angiogenic Effects of Phytochemicals on miRNA Regulating Breast Cancer Progression. Biomolecules 2020;10:E191. [PMID: 32012744 DOI: 10.3390/biom10020191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
17 Legg JA, Herbert JM, Clissold P, Bicknell R. Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration. Angiogenesis 2008;11:13-21. [PMID: 18264786 DOI: 10.1007/s10456-008-9100-x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 110] [Article Influence: 8.2] [Reference Citation Analysis]
18 Kalkunte S, Huang Z, Lippe E, Kumar S, Robertson LW, Sharma S. Polychlorinated biphenyls target Notch/Dll and VEGF R2 in the mouse placenta and human trophoblast cell lines for their anti-angiogenic effects. Sci Rep 2017;7:39885. [PMID: 28071720 DOI: 10.1038/srep39885] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
19 Dong X, Wang YS, Dou GR, Hou HY, Shi YY, Zhang R, Ma K, Wu L, Yao LB, Cai Y. Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions. PLoS One. 2011;6:e18481. [PMID: 21526177 DOI: 10.1371/journal.pone.0018481] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
20 Trachsel E, Neri D. Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis. Advanced Drug Delivery Reviews 2006;58:735-54. [DOI: 10.1016/j.addr.2005.11.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
21 Jaud M, Philippe C, Van Den Berghe L, Ségura C, Mazzolini L, Pyronnet S, Laurell H, Touriol C. The PERK Branch of the Unfolded Protein Response Promotes DLL4 Expression by Activating an Alternative Translation Mechanism. Cancers (Basel) 2019;11:E142. [PMID: 30691003 DOI: 10.3390/cancers11020142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jakobsson L, Bentley K, Gerhardt H. VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochem Soc Trans 2009;37:1233-6. [PMID: 19909253 DOI: 10.1042/BST0371233] [Cited by in Crossref: 106] [Cited by in F6Publishing: 68] [Article Influence: 8.8] [Reference Citation Analysis]
23 Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, Sakai Y, Hashida H, Takabayashi A, Sasaki M, Robine S. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell. 2011;19:125-137. [PMID: 21251616 DOI: 10.1016/j.ccr.2010.11.008] [Cited by in Crossref: 152] [Cited by in F6Publishing: 137] [Article Influence: 13.8] [Reference Citation Analysis]
24 Liu Z, Fan F, Wang A, Zheng S, Lu Y. Dll4-Notch signaling in regulation of tumor angiogenesis. J Cancer Res Clin Oncol 2014;140:525-36. [DOI: 10.1007/s00432-013-1534-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
25 Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134:2709-2718. [PMID: 17611219 DOI: 10.1242/dev.004184] [Cited by in Crossref: 289] [Cited by in F6Publishing: 278] [Article Influence: 19.3] [Reference Citation Analysis]
26 Fu Y, Chang AC, Fournier M, Chang L, Niessen K, Karsan A. RUNX3 maintains the mesenchymal phenotype after termination of the Notch signal. J Biol Chem 2011;286:11803-13. [PMID: 21288908 DOI: 10.1074/jbc.M111.222331] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
27 Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008;27:5132-5137. [PMID: 18758482 DOI: 10.1038/onc.2008.227] [Cited by in Crossref: 180] [Cited by in F6Publishing: 174] [Article Influence: 12.9] [Reference Citation Analysis]
28 Javerzat S, Auguste P, Bikfalvi A. The role of fibroblast growth factors in vascular development. Trends in Molecular Medicine 2002;8:483-9. [DOI: 10.1016/s1471-4914(02)02394-8] [Cited by in Crossref: 183] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
29 Ball DW, Leach SD. Notch in malignancy. Cancer Treat Res 2003;115:95-121. [PMID: 12613194 DOI: 10.1007/0-306-48158-8_4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
30 Diez H, Fischer A, Winkler A, Hu CJ, Hatzopoulos AK, Breier G, Gessler M. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res. 2007;313:1-9. [PMID: 17045587 DOI: 10.1016/j.yexcr.2006.09.009] [Cited by in Crossref: 140] [Cited by in F6Publishing: 136] [Article Influence: 8.8] [Reference Citation Analysis]
31 Bikfalvi A, Bicknell R. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol Sci. 2002;23:576-582. [PMID: 12457776 DOI: 10.1016/s0165-6147(02)02109-0] [Cited by in Crossref: 100] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
32 Shi W, Harris AL. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia. 2006;11:41-52. [PMID: 16947085 DOI: 10.1007/s10911-006-9011-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
33 Rocha SF, Adams RH. Molecular differentiation and specialization of vascular beds. Angiogenesis. 2009;12:139-147. [PMID: 19212819 DOI: 10.1007/s10456-009-9132-x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.2] [Reference Citation Analysis]
34 Huang QB, Ma X, Zhang X, Liu SW, Ai Q, Shi TP, Zhang Y, Gao Y, Fan Y, Ni D, Wang BJ, Li HZ, Zheng T. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4. PLoS One 2013;8:e67294. [PMID: 23826258 DOI: 10.1371/journal.pone.0067294] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
35 Kume T. Ligand-dependent Notch signaling in vascular formation. Adv Exp Med Biol 2012;727:210-22. [PMID: 22399350 DOI: 10.1007/978-1-4614-0899-4_16] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
36 Jubb AM, Turley H, Moeller HC, Steers G, Han C, Li JL, Leek R, Tan EY, Singh B, Mortensen NJ. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer. Br J Cancer. 2009;101:1749-1757. [PMID: 19844231 DOI: 10.1038/sj.bjc.6605368] [Cited by in Crossref: 78] [Cited by in F6Publishing: 75] [Article Influence: 6.0] [Reference Citation Analysis]
37 Paris D, Quadros A, Patel N, DelleDonne A, Humphrey J, Mullan M. Inhibition of angiogenesis and tumor growth by beta and gamma-secretase inhibitors. Eur J Pharmacol 2005;514:1-15. [PMID: 15878319 DOI: 10.1016/j.ejphar.2005.02.050] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
38 Jun HT, Stevens J, Kaplan-lefko P. Top NOTCH targets: notch signaling in cancer. Drug Dev Res 2008;69:319-28. [DOI: 10.1002/ddr.20264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Noguera-Troise I, Daly C, Papadopoulos NJ, Coetzee S, Boland P, Gale NW, Lin HC, Yancopoulos GD, Thurston G. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature. 2006;444:1032-1037. [PMID: 17183313 DOI: 10.1038/nature05355] [Cited by in Crossref: 730] [Cited by in F6Publishing: 681] [Article Influence: 48.7] [Reference Citation Analysis]
40 Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, Thennavan A, Wang C, Torpy JR, Bartonicek N, Wang T, Larsson L, Kaczorowski D, Weisenfeld NI, Uytingco CR, Chew JG, Bent ZW, Chan CL, Gnanasambandapillai V, Dutertre CA, Gluch L, Hui MN, Beith J, Parker A, Robbins E, Segara D, Cooper C, Mak C, Chan B, Warrier S, Ginhoux F, Millar E, Powell JE, Williams SR, Liu XS, O'Toole S, Lim E, Lundeberg J, Perou CM, Swarbrick A. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet 2021;53:1334-47. [PMID: 34493872 DOI: 10.1038/s41588-021-00911-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
41 Locatelli M, Curigliano G. Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures. Current Opinion in Oncology 2017;29:411-27. [DOI: 10.1097/cco.0000000000000406] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
42 Wang S, Zhou R, Sun F, Li R, Wang M, Wu M. The two novel DLL4-targeting antibody-drug conjugates MvM03 and MGD03 show potent anti-tumour activity in breast cancer xenograft models. Cancer Lett 2017;409:125-36. [PMID: 28923397 DOI: 10.1016/j.canlet.2017.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
43 Schadler KL, Zweidler-McKay PA, Guan H, Kleinerman ES. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma. Clin Cancer Res 2010;16:848-56. [PMID: 20103680 DOI: 10.1158/1078-0432.CCR-09-1299] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
44 El Hindy N, Keyvani K, Pagenstecher A, Dammann P, Sandalcioglu IE, Sure U, Zhu Y. Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme. Neuro Oncol 2013;15:1366-78. [PMID: 23787764 DOI: 10.1093/neuonc/not071] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
45 Tung JJ, Tattersall IW, Kitajewski J. Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis. Cold Spring Harb Perspect Med 2012;2:a006601. [PMID: 22355796 DOI: 10.1101/cshperspect.a006601] [Cited by in Crossref: 57] [Cited by in F6Publishing: 66] [Article Influence: 6.3] [Reference Citation Analysis]
46 Weng AP, Lau A. Notch signaling in T-cell acute lymphoblastic leukemia. Future Oncol 2005;1:511-9. [PMID: 16556027 DOI: 10.2217/14796694.1.4.511] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
47 Fernández M, Semela D, Bruix J, Colle I, Pinzani M, Bosch J. Angiogenesis in liver disease. J Hepatol. 2009;50:604-620. [PMID: 19157625 DOI: 10.1016/j.jhep.2008.12.011] [Cited by in Crossref: 381] [Cited by in F6Publishing: 361] [Article Influence: 27.2] [Reference Citation Analysis]
48 Stockhausen MT, Kristoffersen K, Poulsen HS. The functional role of Notch signaling in human gliomas. Neuro Oncol 2010;12:199-211. [PMID: 20150387 DOI: 10.1093/neuonc/nop022] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
49 Ma D, Dong X, Zang S, Ma R, Zhao P, Guo D, Dai J, Chen F, Ye J, Ji C. Aberrant expression and clinical correlation of Notch signaling molecules in breast cancer of Chinese population. Asia Pac J Clin Oncol 2011;7:385-91. [PMID: 22151989 DOI: 10.1111/j.1743-7563.2011.01433.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
50 Nimmagadda S, Geetha-Loganathan P, Pröls F, Scaal M, Christ B, Huang R. Expression pattern of Dll4 during chick embryogenesis. Histochem Cell Biol 2007;128:147-52. [PMID: 17605027 DOI: 10.1007/s00418-007-0306-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
51 Zhou W, Wang G, Guo S. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2013;1836:304-320. [PMID: 24183943 DOI: 10.1016/j.bbcan.2013.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
52 Kalantari E, Saeidi H, Kia NS, Tahergorabi Z, Rashidi B, Dana N, Khazaei M. Effect of DAPT, a gamma secretase inhibitor, on tumor angiogenesis in control mice. Adv Biomed Res 2013;2:83. [PMID: 24520550 DOI: 10.4103/2277-9175.122498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
53 Gerritsen ME. Angiogenesis. Microcirculation. Elsevier; 2008. pp. 351-83. [DOI: 10.1016/b978-0-12-374530-9.00008-5] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
54 Li JL, Jubb AM, Harris AL. Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity. Future Oncol 2010;6:1099-103. [PMID: 20624122 DOI: 10.2217/fon.10.62] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
55 Kuhnert F, Kirshner JR, Thurston G. Dll4-Notch signaling as a therapeutic target in tumor angiogenesis. Vasc Cell. 2011;3:20. [PMID: 21923938 DOI: 10.1186/2045-824x-3-20] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 7.2] [Reference Citation Analysis]
56 Thurston G, Noguera-Troise I, Yancopoulos GD. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer. 2007;7:327-331. [PMID: 17457300 DOI: 10.1038/nrc2130] [Cited by in Crossref: 211] [Cited by in F6Publishing: 205] [Article Influence: 14.1] [Reference Citation Analysis]
57 Duran CL, Howell DW, Dave JM, Smith RL, Torrie ME, Essner JJ, Bayless KJ. Molecular Regulation of Sprouting Angiogenesis. Compr Physiol 2017;8:153-235. [PMID: 29357127 DOI: 10.1002/cphy.c160048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
58 Reis M, Czupalla CJ, Ziegler N, Devraj K, Zinke J, Seidel S, Heck R, Thom S, Macas J, Bockamp E, Fruttiger M, Taketo MM, Dimmeler S, Plate KH, Liebner S. Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J Exp Med 2012;209:1611-27. [PMID: 22908324 DOI: 10.1084/jem.20111580] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 8.3] [Reference Citation Analysis]
59 Swift MR, Weinstein BM. Arterial-venous specification during development. Circ Res 2009;104:576-88. [PMID: 19286613 DOI: 10.1161/CIRCRESAHA.108.188805] [Cited by in Crossref: 275] [Cited by in F6Publishing: 169] [Article Influence: 21.2] [Reference Citation Analysis]
60 Ding XY, Ding J, Wu K, Wen W, Liu C, Yan HX, Chen C, Wang S, Tang H, Gao CK. Cross-talk between endothelial cells and tumor via delta-like ligand 4/Notch/PTEN signaling inhibits lung cancer growth. Oncogene. 2012;31:2899-2906. [PMID: 22002304 DOI: 10.1038/onc.2011.467] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
61 Meng L, Hu S, Wang J, He S, Zhang Y. DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses. Pharmacol Res. 2016;113:449-457. [PMID: 27639599 DOI: 10.1016/j.phrs.2016.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
62 Leong KG, Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood. 2006;107:2223-2233. [PMID: 16291593 DOI: 10.1182/blood-2005-08-3329] [Cited by in Crossref: 364] [Cited by in F6Publishing: 328] [Article Influence: 21.4] [Reference Citation Analysis]
63 Segarra M, Williams CK, Sierra Mde L, Bernardo M, McCormick PJ, Maric D, Regino C, Choyke P, Tosato G. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood 2008;112:1904-11. [PMID: 18577711 DOI: 10.1182/blood-2007-11-126045] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
64 Karsan A. The role of notch in modeling and maintaining the vasculature. Can J Physiol Pharmacol 2005;83:14-23. [DOI: 10.1139/y04-125] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
65 Saltarella I, Frassanito MA, Lamanuzzi A, Brevi A, Leone P, Desantis V, Di Marzo L, Bellone M, Derudas D, Ribatti D, Chiaramonte R, Palano MT, Neri A, Mariggiò MA, Fumarulo R, Dammacco F, Racanelli V, Vacca A, Ria R. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target? Neoplasia 2019;21:93-105. [PMID: 30529074 DOI: 10.1016/j.neo.2018.10.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
66 Jubb AM, Soilleux EJ, Turley H, Steers G, Parker A, Low I, Blades J, Li JL, Allen P, Leek R. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer. Am J Pathol. 2010;176:2019-2028. [PMID: 20167860 DOI: 10.2353/ajpath.2010.090908] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 6.4] [Reference Citation Analysis]
67 Trindade A, Djokovic D, Gigante J, Mendonça L, Duarte A. Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo. BMC Cancer 2017;17:189. [PMID: 28288569 DOI: 10.1186/s12885-017-3171-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
68 Wang W, Yu Y, Wang Y, Li X, Bao J, Wu G, Chang H, Shi T, Yue Z. Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma. Oncol Lett 2014;8:2627-33. [PMID: 25364440 DOI: 10.3892/ol.2014.2554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
69 Li YQ, Liu HY, Cao LL, Wu YY, Shi XW, Qiao FY, Feng L, Deng DR, Gong X. Hypoxia downregulates the angiogenesis in human placenta via Notch1 signaling pathway. J Huazhong Univ Sci Technolog Med Sci 2017;37:541-6. [PMID: 28786053 DOI: 10.1007/s11596-017-1770-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
70 Qiu XX, Chen L, Wang CH, Lin ZX, Zhou CF, Liu SY, Wang XF, Chen YP. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma. Medicine (Baltimore) 2014;93:e57. [PMID: 25121357 DOI: 10.1097/MD.0000000000000057] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
71 Tetzlaff F, Fischer A. Control of Blood Vessel Formation by Notch Signaling. Adv Exp Med Biol 2018;1066:319-38. [PMID: 30030834 DOI: 10.1007/978-3-319-89512-3_16] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
72 Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci U S A. 2004;101:15949-15954. [PMID: 15520367 DOI: 10.1073/pnas.0407290101] [Cited by in Crossref: 434] [Cited by in F6Publishing: 394] [Article Influence: 24.1] [Reference Citation Analysis]
73 Spasic M, Chow F, Tu C, Nagasawa DT, Yang I. Molecular Characteristics and Pathways of Avastin for the Treatment of Glioblastoma Multiforme. Neurosurgery Clinics of North America 2012;23:417-27. [DOI: 10.1016/j.nec.2012.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fang Y, Yu S, Ma Y, Sun P, Ma D, Ji C, Kong B. Association of Dll4/notch and HIF-1a -VEGF signaling in the angiogenesis of missed abortion. PLoS One 2013;8:e70667. [PMID: 23950980 DOI: 10.1371/journal.pone.0070667] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
75 Carroll KD, Bu W, Palmeri D, Spadavecchia S, Lynch SJ, Marras SA, Tyagi S, Lukac DM. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J Virol 2006;80:9697-709. [PMID: 16973574 DOI: 10.1128/JVI.00746-06] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
76 Abbas OL, Borman H, Terzi YK, Terzi A, Bayraktar N, Yazıcı AC. The Notch pathway is a critical regulator of angiogenesis in a skin model of ischemia. Vasc Med 2015;20:205-11. [PMID: 25834117 DOI: 10.1177/1358863X15570723] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
77 Thurston G, Gale NW. Vascular endothelial growth factor and other signaling pathways in developmental and pathologic angiogenesis. Int J Hematol 2004;80:7-20. [PMID: 15293563 DOI: 10.1532/ijh97.04065] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
78 Albig AR, Becenti DJ, Roy TG, Schiemann WP. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc Res 2008;76:7-14. [PMID: 18417156 DOI: 10.1016/j.mvr.2008.01.001] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
79 Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60:222-243. [PMID: 20554717 DOI: 10.3322/caac.20075] [Cited by in Crossref: 311] [Cited by in F6Publishing: 273] [Article Influence: 25.9] [Reference Citation Analysis]
80 Dong Y, Zhang T, Li J, Deng H, Song Y, Zhai D, Peng Y, Lu X, Liu M, Zhao Y, Yi Z. Oridonin inhibits tumor growth and metastasis through anti-angiogenesis by blocking the Notch signaling. PLoS One 2014;9:e113830. [PMID: 25485753 DOI: 10.1371/journal.pone.0113830] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
81 Kumar A, Desai S, Pandey BN. Endothelial Dll4-Notch signaling in tumor microenvironment: is there any hidden therapeutic opportunity? Transl Lung Cancer Res 2013;2:439-41. [PMID: 25806265 DOI: 10.3978/j.issn.2218-6751.2013.09.01] [Reference Citation Analysis]
82 Gridley T. Notch signaling in the vasculature. Curr Top Dev Biol 2010;92:277-309. [PMID: 20816399 DOI: 10.1016/S0070-2153(10)92009-7] [Cited by in Crossref: 178] [Cited by in F6Publishing: 115] [Article Influence: 14.8] [Reference Citation Analysis]
83 Charreau B. Signaling of endothelial cytoprotection in transplantation. Human Immunology 2012;73:1245-52. [DOI: 10.1016/j.humimm.2012.07.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
84 Khan KA, Bicknell R. Anti-angiogenic alternatives to VEGF blockade. Clin Exp Metastasis 2016;33:197-210. [PMID: 26620208 DOI: 10.1007/s10585-015-9769-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
85 Huang Q, Li J, Zheng J, Wei A. The Carcinogenic Role of the Notch Signaling Pathway in the Development of Hepatocellular Carcinoma. J Cancer. 2019;10:1570-1579. [PMID: 31031867 DOI: 10.7150/jca.26847] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
86 Kongkavitoon P, Tangkijvanich P, Hirankarn N, Palaga T. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma. PLoS One. 2016;11:e0146696. [PMID: 26766040 DOI: 10.1371/journal.pone.0146696] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
87 Dergilev KV, Zubkova ЕS, Beloglazova IB, Menshikov МY, Parfyonova ЕV. Notch signal pathway - therapeutic target for regulation of reparative processes in the heart. Ter Arkh 2018;90:112-21. [PMID: 30701843 DOI: 10.26442/00403660.2018.12.000014] [Reference Citation Analysis]
88 Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 2011;11:338-51. [DOI: 10.1038/nrc3035] [Reference Citation Analysis]
89 Zhang Y, Xie ZY, Guo XT, Xiao XH, Xiong LX. Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy. Oncol Lett 2019;18:2743-55. [PMID: 31452752 DOI: 10.3892/ol.2019.10653] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
90 Perlman BE, Merriam AA, Lemenze A, Zhao Q, Begum S, Nair M, Wu T, Wapner RJ, Kitajewski JK, Shawber CJ, Douglas NC. Implications for preeclampsia: hypoxia-induced Notch promotes trophoblast migration. Reproduction 2021;161:681-96. [PMID: 33784241 DOI: 10.1530/REP-20-0483] [Reference Citation Analysis]
91 Morris EV, Edwards CM. Morphogens and growth factor signalling in the myeloma bone-lining niche. Cell Mol Life Sci 2021;78:4085-93. [PMID: 33570672 DOI: 10.1007/s00018-021-03767-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Ferrara N. Pathways mediating VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev. 2010;21:21-26. [PMID: 20005148 DOI: 10.1016/j.cytogfr.2009.11.003] [Cited by in Crossref: 199] [Cited by in F6Publishing: 178] [Article Influence: 15.3] [Reference Citation Analysis]
93 Thurston G, Kitajewski J. VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer. 2008;99:1204-1209. [PMID: 18827808 DOI: 10.1038/sj.bjc.6604484] [Cited by in Crossref: 116] [Cited by in F6Publishing: 107] [Article Influence: 8.3] [Reference Citation Analysis]
94 Herman AM, Rhyner AM, Devine WP, Marrelli SP, Bruneau BG, Wythe JD. A novel reporter allele for monitoring Dll4 expression within the embryonic and adult mouse. Biol Open 2018;7:bio026799. [PMID: 29437553 DOI: 10.1242/bio.026799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
95 Dando JS, Tavian M, Catelain C, Poirault S, Bennaceur-Griscelli A, Sainteny F, Vainchenker W, Péault B, Lauret E. Notch/Delta4 interaction in human embryonic liver CD34+ CD38- cells: positive influence on BFU-E production and LTC-IC potential maintenance. Stem Cells 2005;23:550-60. [PMID: 15790776 DOI: 10.1634/stemcells.2004-0205] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
96 Zhang J, Gao H, Zhang Y. Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes. Oncol Lett 2017;13:4533-9. [PMID: 28599454 DOI: 10.3892/ol.2017.5997] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
97 Mckeage MJ, Kotasek D, Markman B, Hidalgo M, Millward MJ, Jameson MB, Harris DL, Stagg RJ, Kapoun AM, Xu L, Hughes BGM. Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC. Targ Oncol 2018;13:89-98. [DOI: 10.1007/s11523-017-0543-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
98 Abbas OL, Borman H, Terzi YK, Terzi A, Bayraktar N, Özkan B, Yazici AC. Inhibition of the Notch Pathway Promotes Flap Survival by Inducing Functional Neoangiogenesis. Annals of Plastic Surgery 2015;75:455-62. [DOI: 10.1097/sap.0000000000000197] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
99 Dos Santos SN, Sheldon H, Pereira JX, Paluch C, Bridges EM, El-Cheikh MC, Harris AL, Bernardes ES. Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation. Oncotarget 2017;8:49484-501. [PMID: 28533486 DOI: 10.18632/oncotarget.17718] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
100 Timmerman LA, Grego-Bessa J, Raya A, Bertrán E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick F, Izpisúa-Belmonte JC. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18:99-115. [PMID: 14701881 DOI: 10.1101/gad.276304] [Cited by in Crossref: 650] [Cited by in F6Publishing: 611] [Article Influence: 34.2] [Reference Citation Analysis]
101 Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006;107:931-9. [PMID: 16219802 DOI: 10.1182/blood-2005-03-1000] [Cited by in Crossref: 260] [Cited by in F6Publishing: 254] [Article Influence: 15.3] [Reference Citation Analysis]
102 Noseda M, Chang L, McLean G, Grim JE, Clurman BE, Smith LL, Karsan A. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: role of p21Cip1 repression. Mol Cell Biol 2004;24:8813-22. [PMID: 15456857 DOI: 10.1128/MCB.24.20.8813-8822.2004] [Cited by in Crossref: 159] [Cited by in F6Publishing: 87] [Article Influence: 8.8] [Reference Citation Analysis]
103 Hosni A, El-Twab SA, Abdul-Hamid M, Prinsen E, AbdElgawad H, Abdel-Moneim A, Beemster GTS. Cinnamaldehyde mitigates placental vascular dysfunction of gestational diabetes and protects from the associated fetal hypoxia by modulating placental angiogenesis, metabolic activity and oxidative stress. Pharmacol Res 2021;165:105426. [PMID: 33453370 DOI: 10.1016/j.phrs.2021.105426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Sweeney C, Morrow D, Birney YA, Coyle S, Hennessy C, Scheller A, Cummins PM, Walls D, Redmond EM, Cahill PA. Notch 1 and 3 receptors modulate vascular smooth muscle cell growth, apoptosis and migration via a CBF‐1/RBP‐Jk dependent pathway. FASEB j 2004;18:1421-3. [DOI: 10.1096/fj.04-1700fje] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
105 Sullivan DC, Bicknell R. New molecular pathways in angiogenesis. Br J Cancer 2003;89:228-31. [PMID: 12865906 DOI: 10.1038/sj.bjc.6601107] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.4] [Reference Citation Analysis]
106 Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer. 2005;5:436-446. [PMID: 15928674 DOI: 10.1038/nrc1627] [Cited by in Crossref: 460] [Cited by in F6Publishing: 406] [Article Influence: 27.1] [Reference Citation Analysis]
107 Oon CE, Harris AL. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis. Biochem Soc Trans. 2011;39:1612-1618. [PMID: 22103496 DOI: 10.1042/bst20110721] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
108 Su S, Mendoza EA, Kwak H, Bayless KJ. Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing. American Journal of Physiology-Cell Physiology 2008;295:C1215-29. [DOI: 10.1152/ajpcell.00336.2008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
109 Li JL, Harris AL. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell. 2005;8:1-3. [PMID: 16023591 DOI: 10.1016/j.ccr.2005.06.013] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
110 Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis. BMC Cancer 2010;10:641. [PMID: 21092311 DOI: 10.1186/1471-2407-10-641] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 5.6] [Reference Citation Analysis]
111 Al Haj Zen A, Oikawa A, Bazan-Peregrino M, Meloni M, Emanueli C, Madeddu P. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circ Res 2010;107:283-93. [PMID: 20508179 DOI: 10.1161/CIRCRESAHA.110.221663] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
112 Scehnet JS, Jiang W, Kumar SR, Krasnoperov V, Trindade A, Benedito R, Djokovic D, Borges C, Ley EJ, Duarte A. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood. 2007;109:4753-4760. [PMID: 17311993 DOI: 10.1182/blood-2006-12-063933] [Cited by in Crossref: 178] [Cited by in F6Publishing: 167] [Article Influence: 11.9] [Reference Citation Analysis]
113 Geers C, Colin IM, Gérard AC. Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. Thyroid 2011;21:1323-30. [PMID: 22066479 DOI: 10.1089/thy.2010.0444] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
114 Mao H, Graziano JJ, Chase TM, Bentley CA, Bazirgan OA, Reddy NP, Song BD, Smider VV. Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization. Nat Biotechnol 2010;28:1195-202. [PMID: 20972421 DOI: 10.1038/nbt.1694] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
115 Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011;11:338-351. [PMID: 21508972 DOI: 10.1038/nrc3035] [Cited by in Crossref: 523] [Cited by in F6Publishing: 496] [Article Influence: 47.5] [Reference Citation Analysis]
116 Chen HF, Wu KJ. Endothelial Transdifferentiation of Tumor Cells Triggered by the Twist1-Jagged1-KLF4 Axis: Relationship between Cancer Stemness and Angiogenesis. Stem Cells Int 2016;2016:6439864. [PMID: 26823670 DOI: 10.1155/2016/6439864] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
117 Gallego GA, Villaamil VM, Grande E, Caínzos IS, Aparicio LM. Crossing paths in Human Renal Cell Carcinoma (hRCC). Int J Mol Sci 2012;13:12710-33. [PMID: 23202921 DOI: 10.3390/ijms131012710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
118 Reinacher-Schick A, Pohl M, Schmiegel W. Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies. Nat Clin Pract Gastroenterol Hepatol 2008;5:250-67. [PMID: 18382435 DOI: 10.1038/ncpgasthep1097] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
119 Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta. 2011;1815:197-213. [PMID: 21193018 DOI: 10.1016/j.bbcan.2010.12.002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 116] [Article Influence: 3.9] [Reference Citation Analysis]
120 Cheng WK, Oon CE. How glycosylation aids tumor angiogenesis: An updated review.Biomed Pharmacother. 2018;103:1246-1252. [PMID: 29864905 DOI: 10.1016/j.biopha.2018.04.119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
121 Herbert JM, Stekel D, Sanderson S, Heath VL, Bicknell R. A novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes. BMC Genomics 2008;9:153. [PMID: 18394197 DOI: 10.1186/1471-2164-9-153] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
122 Zhang N, Yin R, Zhou P, Liu X, Fan P, Qian L, Dong L, Zhang C, Zheng X, Deng S, Kuai J, Liu Z, Jiang W, Wang X, Wu D, Huang Y. DLL1 orchestrates CD8+ T cells to induce long-term vascular normalization and tumor regression. Proc Natl Acad Sci U S A 2021;118:e2020057118. [PMID: 34035167 DOI: 10.1073/pnas.2020057118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
123 Hozumi K, Mailhos C, Negishi N, Hirano K, Yahata T, Ando K, Zuklys S, Holländer GA, Shima DT, Habu S. Delta-like 4 is indispensable in thymic environment specific for T cell development. J Exp Med 2008;205:2507-13. [PMID: 18824583 DOI: 10.1084/jem.20080134] [Cited by in Crossref: 262] [Cited by in F6Publishing: 240] [Article Influence: 18.7] [Reference Citation Analysis]
124 Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A, Karsan A. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J Biol Chem. 2009;284:19452-19462. [PMID: 19473993 DOI: 10.1074/jbc.m109.011833] [Cited by in Crossref: 76] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
125 Shawber CJ, Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays. 2004;26:225-234. [PMID: 14988924 DOI: 10.1002/bies.20004] [Cited by in Crossref: 158] [Cited by in F6Publishing: 163] [Article Influence: 8.8] [Reference Citation Analysis]
126 Hofmann JJ, Iruela-Arispe ML. Notch signaling in blood vessels: who is talking to whom about what? Circ Res. 2007;100:1556-1568. [PMID: 17556669 DOI: 10.1161/01.res.0000266408.42939.e4] [Cited by in Crossref: 158] [Cited by in F6Publishing: 104] [Article Influence: 10.5] [Reference Citation Analysis]
127 Yang S, Liu Y, Xia B, Deng J, Liu T, Li Q, Yang Y, Wang Y, Ning X, Zhang Y, Xiao M. DLL4 as a predictor of pelvic lymph node metastasis and a novel prognostic biomarker in patients with early-stage cervical cancer. Tumour Biol 2016;37:5063-74. [PMID: 26546434 DOI: 10.1007/s13277-015-4312-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
128 Oishi H, Sunamura M, Egawa S, Motoi F, Unno M, Furukawa T, Habib NA, Yagita H. Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer. Pancreas. 2010;39:897-903. [PMID: 20182391 DOI: 10.1097/mpa.0b013e3181ce7185] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
129 Sainson RC, Johnston DA, Chu HC, Holderfield MT, Nakatsu MN, Crampton SP, Davis J, Conn E, Hughes CC. TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype. Blood. 2008;111:4997-5007. [PMID: 18337563 DOI: 10.1182/blood-2007-08-108597] [Cited by in Crossref: 200] [Cited by in F6Publishing: 202] [Article Influence: 14.3] [Reference Citation Analysis]
130 Ishigami S, Arigami T, Uenosono Y, Okumura H, Kurahara H, Uchikado Y, Setoyama T, Kita Y, Kijima Y, Nishizono Y. Clinical implications of DLL4 expression in gastric cancer. J Exp Clin Cancer Res. 2013;32:46. [PMID: 23898884 DOI: 10.1186/1756-9966-32-46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
131 Gharaibeh L, Elmadany N, Alwosaibai K, Alshaer W. Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges. Mol Pharmacol 2020;98:559-76. [PMID: 32913140 DOI: 10.1124/molpharm.120.000006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
132 Reedijk M. Notch Signaling and Breast Cancer. In: Reichrath J, Reichrath S, editors. Notch Signaling in Embryology and Cancer. New York: Springer US; 2012. pp. 241-57. [DOI: 10.1007/978-1-4614-0899-4_18] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
133 Taki A, Abe M, Komaki M, Oku K, Iseki S, Mizutani S, Morita I. Expression of angiogenesis-related factors and inflammatory cytokines in placenta and umbilical vessels in pregnancies with preeclampsia and chorioamnionitis/funisitis. Congenit Anom (Kyoto) 2012;52:97-103. [PMID: 22639995 DOI: 10.1111/j.1741-4520.2012.00359.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
134 Sainson RC, Harris AL. Hypoxia-regulated differentiation: let's step it up a Notch. Trends in Molecular Medicine 2006;12:141-3. [DOI: 10.1016/j.molmed.2006.02.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
135 Pendeville H, Winandy M, Manfroid I, Nivelles O, Motte P, Pasque V, Peers B, Struman I, Martial JA, Voz ML. Zebrafish Sox7 and Sox18 function together to control arterial-venous identity. Dev Biol 2008;317:405-16. [PMID: 18377889 DOI: 10.1016/j.ydbio.2008.01.028] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 6.6] [Reference Citation Analysis]
136 Ubezio B, Blanco RA, Geudens I, Stanchi F, Mathivet T, Jones ML, Ragab A, Bentley K, Gerhardt H. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion. Elife 2016;5:e12167. [PMID: 27074663 DOI: 10.7554/eLife.12167] [Cited by in Crossref: 71] [Cited by in F6Publishing: 46] [Article Influence: 11.8] [Reference Citation Analysis]
137 Kiriakidis S, Henze A, Kruszynska‐ziaja I, Skobridis K, Theodorou V, Paleolog EM, Mazzone M. Factor‐inhibiting HIF‐1 (FIH‐1) is required for human vascular endothelial cell survival. FASEB j 2015;29:2814-27. [DOI: 10.1096/fj.14-252379] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
138 Leslie JD, Ariza-McNaughton L, Bermange AL, McAdow R, Johnson SL, Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007;134:839-44. [PMID: 17251261 DOI: 10.1242/dev.003244] [Cited by in Crossref: 296] [Cited by in F6Publishing: 273] [Article Influence: 19.7] [Reference Citation Analysis]
139 Jia X, Wang W, Xu Z, Wang S, Wang T, Wang M, Wu M. A humanized anti-DLL4 antibody promotes dysfunctional angiogenesis and inhibits breast tumor growth. Sci Rep 2016;6:27985. [PMID: 27301650 DOI: 10.1038/srep27985] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
140 Augustus M, Pineau D, Aimond F, Azar S, Lecca D, Scamps F, Muxel S, Darlix A, Ritchie W, Gozé C, Rigau V, Duffau H, Hugnot JP. Identification of CRYAB+ KCNN3+ SOX9+ Astrocyte-Like and EGFR+ PDGFRA+ OLIG1+ Oligodendrocyte-Like Tumoral Cells in Diffuse IDH1-Mutant Gliomas and Implication of NOTCH1 Signalling in Their Genesis. Cancers (Basel) 2021;13:2107. [PMID: 33925547 DOI: 10.3390/cancers13092107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
141 Chappell JC, Bautch VL. Vascular Development. Organogenesis in Development. Elsevier; 2010. pp. 43-72. [DOI: 10.1016/s0070-2153(10)90002-1] [Cited by in Crossref: 46] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
142 Sainson RCA, Harris AL. Regulation of angiogenesis by homotypic and heterotypic notch signalling in endothelial cells and pericytes: from basic research to potential therapies. Angiogenesis 2008;11:41-51. [DOI: 10.1007/s10456-008-9098-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
143 Bautch VL, Caron KM. Blood and lymphatic vessel formation. Cold Spring Harb Perspect Biol 2015;7:a008268. [PMID: 25731762 DOI: 10.1101/cshperspect.a008268] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
144 Bhattarai P, Hameed S, Dai Z. Recent advances in anti-angiogenic nanomedicines for cancer therapy. Nanoscale 2018;10:5393-423. [DOI: 10.1039/c7nr09612g] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
145 Urness LD, Li DY. Wiring the vascular circuitry: from growth factors to guidance cues. Curr Top Dev Biol 2004;62:87-126. [PMID: 15522740 DOI: 10.1016/S0070-2153(04)62004-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
146 Jamshidi-Parsian A, Griffin RJ, Kore RA, Todorova VK, Makhoul I. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma. Exp Cell Res 2018;372:16-24. [PMID: 30205087 DOI: 10.1016/j.yexcr.2018.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Kamath AV, Yip V, Gupta P, Boswell CA, Bumbaca D, Haughney P, Castro J, Tsai SP, Pacheco G, Ross S, Yan M, Damico-Beyer LA, Khawli L, Shen BQ. Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice. MAbs 2014;6:1631-7. [PMID: 25484068 DOI: 10.4161/mabs.36107] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
148 Benedito R, Duarte A. Expression of Dll4 during mouse embryogenesis suggests multiple developmental roles. Gene Expr Patterns 2005;5:750-5. [PMID: 15923152 DOI: 10.1016/j.modgep.2005.04.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 4.9] [Reference Citation Analysis]
149 Sorensen LK, Brooke BS, Li DY, Urness LD. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFβ coreceptor. Developmental Biology 2003;261:235-50. [DOI: 10.1016/s0012-1606(03)00158-1] [Cited by in Crossref: 121] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
150 Banerjee D, Hernandez SL, Garcia A, Kangsamaksin T, Sbiroli E, Andrews J, Forrester LA, Wei N, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Res 2015;75:1592-602. [PMID: 25744722 DOI: 10.1158/0008-5472.CAN-14-1493] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
151 Crawford Y, Ferrara N. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies. Trends Pharmacol Sci 2009;30:624-30. [PMID: 19836845 DOI: 10.1016/j.tips.2009.09.004] [Cited by in Crossref: 107] [Cited by in F6Publishing: 89] [Article Influence: 8.9] [Reference Citation Analysis]
152 Yan M. Therapeutic promise and challenges of targeting DLL4/NOTCH1. Vasc Cell. 2011;3:17. [PMID: 21824400 DOI: 10.1186/2045-824x-3-17] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
153 Jovanovic VP, Sauer CM, Shawber CJ, Gomez R, Wang X, Sauer MV, Kitajewski J, Zimmermann RC. Intraovarian regulation of gonadotropin-dependent folliculogenesis depends on notch receptor signaling pathways not involving Delta-like ligand 4 (Dll4). Reprod Biol Endocrinol 2013;11:43. [PMID: 23675950 DOI: 10.1186/1477-7827-11-43] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
154 Ahmed Z, Bicknell R. Angiogenic Signalling Pathways. In: Murray C, Martin S, editors. Angiogenesis Protocols. Totowa: Humana Press; 2009. pp. 3-24. [DOI: 10.1007/978-1-59745-241-0_1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
155 San Juan BP, Garcia-Leon MJ, Rangel L, Goetz JG, Chaffer CL. The Complexities of Metastasis. Cancers (Basel) 2019;11:E1575. [PMID: 31623163 DOI: 10.3390/cancers11101575] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
156 Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
157 Del Barrio MG, Taveira-Marques R, Muroyama Y, Yuk DI, Li S, Wines-Samuelson M, Shen J, Smith HK, Xiang M, Rowitch D, Richardson WD. A regulatory network involving Foxn4, Mash1 and delta-like 4/Notch1 generates V2a and V2b spinal interneurons from a common progenitor pool. Development 2007;134:3427-36. [PMID: 17728344 DOI: 10.1242/dev.005868] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 5.9] [Reference Citation Analysis]
158 Shawber CJ, Funahashi Y, Francisco E, Vorontchikhina M, Kitamura Y, Stowell SA, Borisenko V, Feirt N, Podgrabinska S, Shiraishi K, Chawengsaksophak K, Rossant J, Accili D, Skobe M, Kitajewski J. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. J Clin Invest 2007;117:3369-82. [PMID: 17948123 DOI: 10.1172/JCI24311] [Cited by in Crossref: 111] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
159 Wieland E, Rodriguez-vita J, Liebler SS, Mogler C, Moll I, Herberich SE, Espinet E, Herpel E, Menuchin A, Chang-claude J, Hoffmeister M, Gebhardt C, Brenner H, Trumpp A, Siebel CW, Hecker M, Utikal J, Sprinzak D, Fischer A. Endothelial Notch1 Activity Facilitates Metastasis. Cancer Cell 2017;31:355-67. [DOI: 10.1016/j.ccell.2017.01.007] [Cited by in Crossref: 146] [Cited by in F6Publishing: 128] [Article Influence: 29.2] [Reference Citation Analysis]
160 Liu SK, Bham SA, Fokas E, Beech J, Im J, Cho S, Harris AL, Muschel RJ. Delta-like ligand 4-notch blockade and tumor radiation response. J Natl Cancer Inst. 2011;103:1778-1798. [PMID: 22010178 DOI: 10.1093/jnci/djr419] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
161 Sainson RC, Harris AL. Anti-Dll4 therapy: can we block tumour growth by increasing angiogenesis? Trends Mol Med. 2007;13:389-395. [PMID: 17822956 DOI: 10.1016/j.molmed.2007.07.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
162 Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, Kitajewski J. Notch signaling in developmental and tumor angiogenesis. Genes Cancer 2011;2:1106-16. [PMID: 22866202 DOI: 10.1177/1947601911423030] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 8.9] [Reference Citation Analysis]
163 Blanco R, Gerhardt H. VEGF and Notch in tip and stalk cell selection. Cold Spring Harb Perspect Med 2013;3:a006569. [PMID: 23085847 DOI: 10.1101/cshperspect.a006569] [Cited by in Crossref: 275] [Cited by in F6Publishing: 252] [Article Influence: 30.6] [Reference Citation Analysis]
164 Nickoloff BJ, Osborne BA, Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene. 2003;22:6598-6608. [PMID: 14528285 DOI: 10.1038/sj.onc.1206758] [Cited by in Crossref: 206] [Cited by in F6Publishing: 194] [Article Influence: 10.8] [Reference Citation Analysis]
165 Xu Z, Wang Z, Jia X, Wang L, Chen Z, Wang S, Wang M, Zhang J, Wu M. MMGZ01, an anti-DLL4 monoclonal antibody, promotes nonfunctional vessels and inhibits breast tumor growth. Cancer Lett 2016;372:118-27. [PMID: 26739060 DOI: 10.1016/j.canlet.2015.12.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
166 Wang Q, Shi Y, Butler HJ, Xue J, Wang G, Duan P, Zheng H. Role of delta-like ligand-4 in chemoresistance against docetaxel in MCF-7 cells. Hum Exp Toxicol 2017;36:328-38. [PMID: 27334972 DOI: 10.1177/0960327116650006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
167 Wright GJ, Leslie JD, Ariza-McNaughton L, Lewis J. Delta proteins and MAGI proteins: an interaction of Notch ligands with intracellular scaffolding molecules and its significance for zebrafish development. Development 2004;131:5659-69. [PMID: 15509766 DOI: 10.1242/dev.01417] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
168 Kume T. Novel insights into the differential functions of Notch ligands in vascular formation. J Angiogenes Res. 2009;1:8. [PMID: 20016694 DOI: 10.1186/2040-2384-1-8] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 5.6] [Reference Citation Analysis]
169 Körbel C, Gerstner MD, Menger MD, Laschke MW. Notch signaling controls sprouting angiogenesis of endometriotic lesions. Angiogenesis 2018;21:37-46. [PMID: 28993956 DOI: 10.1007/s10456-017-9580-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
170 Sharma A, Shiras A. Cancer stem cell-vascular endothelial cell interactions in glioblastoma. Biochem Biophys Res Commun 2016;473:688-92. [PMID: 26692486 DOI: 10.1016/j.bbrc.2015.12.022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
171 Rehman AO, Wang CY. Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol 2006;16:293-300. [PMID: 16697642 DOI: 10.1016/j.tcb.2006.04.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
172 Rybak JN, Trachsel E, Scheuermann J, Neri D. Ligand-based vascular targeting of disease. ChemMedChem. 2007;2:22-40. [PMID: 17154429 DOI: 10.1002/cmdc.200600181] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
173 Mariappan D, Winkler J, Hescheler J, Sachinidis A. Cardiovascular genomics: a current overview of in vivo and in vitro studies. Stem Cell Rev 2006;2:59-66. [PMID: 17142888 DOI: 10.1007/s12015-006-0010-2] [Reference Citation Analysis]
174 Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H, Polverini PJ, Nor J, Kitajewski J, Wang CY. Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 2005;8:13-23. [PMID: 16023595 DOI: 10.1016/j.ccr.2005.06.004] [Cited by in Crossref: 246] [Cited by in F6Publishing: 224] [Article Influence: 14.5] [Reference Citation Analysis]
175 Real C, Remédio L, Caiado F, Igreja C, Borges C, Trindade A, Pinto-do-Ó P, Yagita H, Duarte A, Dias S. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis. PLoS One 2011;6:e18323. [PMID: 21483741 DOI: 10.1371/journal.pone.0018323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
176 Alessi P, Ebbinghaus C, Neri D. Molecular targeting of angiogenesis. Biochim Biophys Acta 2004;1654:39-49. [PMID: 14984766 DOI: 10.1016/j.bbcan.2003.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 22] [Article Influence: 0.4] [Reference Citation Analysis]
177 Bridges E, Oon CE, Harris A. Notch regulation of tumor angiogenesis. Future Oncol 2011;7:569-88. [PMID: 21463145 DOI: 10.2217/fon.11.20] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
178 Quillard T, Charreau B. Impact of notch signaling on inflammatory responses in cardiovascular disorders. Int J Mol Sci 2013;14:6863-88. [PMID: 23531541 DOI: 10.3390/ijms14046863] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
179 Gaur P, Bose D, Samuel S, Ellis LM. Targeting tumor angiogenesis. Semin Oncol 2009;36:S12-9. [PMID: 19393831 DOI: 10.1053/j.seminoncol.2009.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
180 Shao H, Cai L, Grichnik JM, Livingstone AS, Velazquez OC, Liu ZJ. Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Oncogene 2011;30:4316-26. [PMID: 21516124 DOI: 10.1038/onc.2011.142] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
181 Bicknell R. An update of new targets for cancer treatment: vessels and matrix. Annals of Oncology 2002;13:25-8. [DOI: 10.1093/annonc/mdf634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
182 Xu X, Wu Y, Li H, Xie J, Cao D, Huang X. Notch pathway inhibitor DAPT accelerates in vitro proliferation and adipogenesis in infantile hemangioma stem cells. Oncol Lett 2021;22:854. [PMID: 34777588 DOI: 10.3892/ol.2021.13115] [Reference Citation Analysis]
183 Stockhausen MT, Kristoffersen K, Poulsen HS. Notch signaling and brain tumors. Adv Exp Med Biol 2012;727:289-304. [PMID: 22399356 DOI: 10.1007/978-1-4614-0899-4_22] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
184 Staton CA, Brown NJ, Reed MW. Current status and future prospects for anti-angiogenic therapies in cancer. Expert Opinion on Drug Discovery 2009;4:961-79. [DOI: 10.1517/17460440903196737] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
185 Hozumi K, Negishi N, Suzuki D, Abe N, Sotomaru Y, Tamaoki N, Mailhos C, Ish-horowicz D, Habu S, Owen MJ. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat Immunol 2004;5:638-44. [DOI: 10.1038/ni1075] [Cited by in Crossref: 247] [Cited by in F6Publishing: 236] [Article Influence: 13.7] [Reference Citation Analysis]
186 Xu L, Li L, Zhang CY, Schluesener H, Zhang ZY. Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway. Front Neurosci. 2019;13:272. [PMID: 31001070 DOI: 10.3389/fnins.2019.00272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
187 Griffin NM, Schnitzer JE. Chapter 8 Proteomic Mapping of the Vascular Endothelium In Vivo for Vascular Targeting. Angiogenesis: In Vivo Systems, Part B. Elsevier; 2008. pp. 177-208. [DOI: 10.1016/s0076-6879(08)03008-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
188 Ghiabi P, Jiang J, Pasquier J, Maleki M, Abu-Kaoud N, Rafii S, Rafii A. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties. PLoS One 2014;9:e112424. [PMID: 25380486 DOI: 10.1371/journal.pone.0112424] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
189 Yamanda S, Ebihara S, Asada M, Okazaki T, Niu K, Ebihara T, Koyanagi A, Yamaguchi N, Yagita H, Arai H. Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade. Blood 2009;113:3631-9. [DOI: 10.1182/blood-2008-07-170381] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
190 Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Pérez-del-Pulgar S, Carpenter PM, Hughes CC. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res 2003;66:102-12. [PMID: 12935768 DOI: 10.1016/s0026-2862(03)00045-1] [Cited by in Crossref: 325] [Cited by in F6Publishing: 161] [Article Influence: 18.1] [Reference Citation Analysis]